ニュース

Labiotech.eu interviewed Natalia Elizalde during Phacilitate’s Advanced Therapies Week congress that took place last week in Miami Beach, Florida.

Natalia Elizalde and Naiara Tejados have participated in a Drug Discovery World cell and gene therapy guide that was recently published.

Naiara Tejados, Head of Marketing and Technology Development, has published an article in The Medicine Maker entitled “Know Your Vectors: a 101 on Lentiviral Therapies”.

All the VIVEbiotech team wishes you a very Merry Christmas and a wonderful 2023!

VIVEbiotech has participated in the 4th edition of the INDUSTRIA EGUNA organised by ADEGI – Business Association of Gipuzkoa.

VIVEbiotech has successfully participated in 7 international events during 2023.

VIVEbiotech has presented a webinar entitled “Flexible and Customized Approach to Lentiviral Vector Development and Manufacture Through a Well-Established Platform” last Tuesday, November 8.

VIVEbiotech has participated in the 4th edition of New Culturers Gunea that took place in FabrikaNCE last 19th October: a very interesting event to show young students how we work and interact in VIVEbiotech to take care of the values of the culture that makes us different and of which we are so proud.

Gurutz Linazasoro, CEO of VIVEbiotech, has participated in the conference called “Terapias avanzadas (TA): de la academia a la industria” organized by AseBio, the Spanish Bioindustry Association and the Centro de Investigación Biomédica en Red (CIBER).

VIVEbiotech has participated in a webinar entitled “The importance of raw materials to succeed in lentiviral vector manufacturing” together with Polyplus.